
CNBC's "Fast Money"
Hosted by Melissa Lee and a roundtable of top traders, “Fast Money” breaks through the noise of the day, to deliver the actionable news that matters most to investors. Fast Money airs weeknights at 5p ET on CNBC. Visit http://fastmoney.cnbc.com for additional information.
Latest episodes

May 8, 2025 • 43min
President Trump Unveils UK Trade Deal Framework… And The Next Move In Pharma 5/8/25
President Trump's new trade deal framework with the UK promises to impact markets in unprecedented ways. The discussion dives into Alphabet's latest challenges amid fierce competition and how pharmaceutical pricing policies could reshape the industry. Insights into the tech sector reveal struggles for giants like Google and Apple. Additionally, the need for aviation safety upgrades is spotlighted alongside Coinbase's earnings and Pinterest's AI-driven strategies to boost engagement. Diverse investment tactics round out the conversation as experts weigh in on potential stock recommendations.

7 snips
May 7, 2025 • 44min
Apple And Alphabet Dip, China Stocks Falter, And Disney’s Whole New World 5/7/25
Apple and Alphabet face a dip as AI and search engine strategies come under scrutiny. China stocks are faltering despite stimulus efforts, with trade tensions lingering. Disney is unveiling plans to expand its magic into the Middle East, while addressing competitive pressures in streaming. Plus, insights on the Federal Reserve's interest rate decisions and their impact on the market add to the economic narrative. As earnings reports come in, analysts weigh in on key market shifts and stock performance.

9 snips
May 6, 2025 • 44min
Fed Decision On Deck… And Novo Nordisk Gears Up To Report 5/6/25
Richard Fisher, a CNBC contributor and former Dallas Fed President, shares insights on the upcoming Federal Reserve decision amid a cooling stock market. He discusses the implications of Fed Chair Jerome Powell's announcements for market direction. With earnings season underway, the conversation shifts to Novo Nordisk's anticipated report, and a healthcare analyst highlights the potential challenges from tariffs and political pressures on the weight loss drug sector. Fisher also explores broader economic concerns and trade uncertainties that could impact market dynamics.

7 snips
May 5, 2025 • 44min
Oil Drops To 4 Year Lows… And Hollywood’s Tariff Threat 5/5/25
Paul Sankey, President and lead analyst at Sankey Research, dives deep into the oil market as prices hit four-year lows. He predicts a price drop to $40 per barrel and discusses the need for reduced U.S. production to restore balance. The conversation also shifts to Hollywood, where Sankey addresses President Trump's potential 100% tariff on overseas films and its looming impact on streaming giants like Netflix. Insights into Ford's unexpected earnings amid these tariff challenges add another layer to this engaging discussion.

May 2, 2025 • 44min
Stocks Close Out Another Strong Week, And Why the Oracle of Omaha May Be Seeing a “Buy” Signal 5/2/25
Major markets soared after a surprisingly strong jobs report and hints of renewed U.S.-China trade talks. There’s buzz around Warren Buffett possibly signaling that market prices are attracting. The conversation shifts to investment strategies in volatile times, including comparisons of Bitcoin and gold. Insights into Netflix’s growth alongside concerns of overvaluation are presented. Finally, the chatter includes a look at collectibles and their investment potential amid ongoing economic uncertainties.

5 snips
May 1, 2025 • 43min
Apple and Amazon Earnings Roll In, Eli Lilly Tanks, And Markets Brace For Jobs Report 5/1/25
Steve Kovac, CNBC's correspondent, and Gene Munster, an analyst from Deepwater Asset Management, delve into the latest earnings reports from heavyweights Apple and Amazon. They discuss Apple's strong performance amidst service challenges and potential tariff impacts. Munster shares insights on Amazon's unexpected cloud growth slowdown, affecting stock reactions. They also touch on Eli Lilly's profit forecast cut and explore market sentiment ahead of a key jobs report, all while naming strategic moves in tech and pharma.

Apr 30, 2025 • 44min
Meta And Microsoft Earnings Roll In, GDP Drops, And Tariff Impact On Retail 04/30/25
A slew of earnings roll in with Meta and Microsoft among the names reporting. Deepwater Asset Management Gene Munster joins to dig into where he sees tech heading next. Plus, markets tumble after a surprise GDP result, Telsey Advisory Group CEO Dana Telsey on the retail impact of tariffs, and how Starbucks is faring after their disappointing results. Fast Money Disclaimer

Apr 29, 2025 • 44min
Trump’s Second First 100 Days… And Auto Tariff Reprieve Description 04/29/25
Dive into the economic rollercoaster of President Trump's second 100 days in office, as stocks face their worst start since Nixon. Discuss the halt on auto tariffs and what it means for automakers racing against time. Unpack the uncertainty clouding earnings season with major companies suspending guidance, and analyze NVIDIA's revenue struggles impacting the semiconductor industry. Explore healthcare innovations aimed at improving patient access and see how poker strategies reveal insights into market trends.

Apr 28, 2025 • 44min
Big Tech On Deck, A Transports Warning… And Foreign Money At Risk 4/28/25
In this discussion, Rebecca Patterson, former chief strategist at Bridgewater, dives into the heightened expectations surrounding big tech earnings and the potential challenges for key players like Google and Amazon. The conversation highlights alarming indicators in the transport sector and bearish sentiments in pharma stocks as they face significant hurdles. Patterson also explores the implications of U.S.-China trade tensions on foreign investment, raising concerns about a potential withdrawal of foreign capital from U.S. assets.

11 snips
Apr 25, 2025 • 43min
Stocks Wrap Up A Positive Week.. And How Pharma Will Fare Under Tariffs 4/25/25
Stocks closing out a positive week, as tech stocks lead the market bounce with a big move off its recent lows. How our traders are positioning ahead of another big week of earnings, headlined by Apple, Microsoft, and Meta. Plus A major pharma fee. The $51 billion Trump’s tariffs could add to U.S. drug costs, and where one industry expert is still seeing opportunity in the space. Fast Money Disclaimer
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.